Candida glabrata: an emerging pathogen in Brazilian tertiary care hospitals

References

• Arnold HM, Micek ST, Shorr AF, . Hospital resource utilization and costs of inappropriate treatment of candidemia. Pharmacother 2010; 30: 361–368.
   PubMed Web of Science ®Google Scholar
• Zilberberg MD, Kollef MH, Arnold H, . Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study. BMC Infect Dis 2010; 10: 150.
   Web of Science ®Google Scholar
• Colombo AL, Guimaraes T, Silva LRBF, . Prospective observational study of candidemia in Sao Paulo, Brazil: Incidence rate, epidemiology, and predictors of mortality. Infect Cont Hosp Epidemiol 2007; 28: 570–576.
   PubMed Web of Science ®Google Scholar
• Nucci M, Queiroz-Telles F, Tobon AM, Restrepo A, Colombo AL.Epidemiology of opportunistic fungal infections in Latin America. Clin Infect Dis 2010; 51: 561–570.
   PubMed Web of Science ®Google Scholar
• Pasqualotto AC, Zimerman RA, Alves SH, . Take control over your fluconazole prescriptions: The growing importance of Candida glabrata as an agent of candidemia in Brazil. Infect Cont Hosp Epidemiol 2008; 29: 898–899.
   PubMed Web of Science ®Google Scholar
• Wunsch H, Angus DC, Harrison DA, . Variation in critical care services across North America and Western Europe. Crit Care Med 2008; 36: 2787–2793.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved standard-M27-A3 3rd ed. Wayne, PA: Clinical and Laboratory Standards Institute, 2008.
   Google Scholar
• Nguyen MH, Clancy CJ, Yu VL, . Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia.J Infect Dis 1998; 177: 425–430.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Andes D, Diekema DJ, . Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods. Drug Resist Update 2010; 13: 180–195.
   PubMed Web of Science ®Google Scholar
• Colombo AL, Nucci M, Park BJ, . Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol 2006; 44: 2816–2823.
   PubMed Web of Science ®Google Scholar
• Asmundsdottir LR, Erlendsdottir H, Gottfredsson M.Increasing incidence of candidemia: results from a 20-year nationwide study in Iceland. J Clin Microbiol 2002; 40: 3489–3492.
   PubMed Web of Science ®Google Scholar
• Horn DL, Neofytos D, Anaissie EJ, . Epidemiology and outcomes of candidemia in 2019 patients: Data from the Prospective Antifungal Therapy Alliance Registry. Clin Infect Dis 2009; 48: 1695–1703.
   PubMed Web of Science ®Google Scholar
• Leroy O, Gangneux JP, Montravers P, . Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005–2006). Crit Care Med 2009; 37: 1612–1618.
   PubMed Web of Science ®Google Scholar
• Shaw AB.Age as a basis for healthcare rationing – support for agist policies. Drug Aging 1996; 9: 403–405.
   PubMed Web of Science ®Google Scholar
• Lloyd-Sherlock P.Population ageing in developed and developing regions: implications for health policy. Soc Sci Med 2000; 51: 887–895.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ, Gibbs DL, . Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program. Diagn Microbiol Infect Dis 2010; 67: 162–171.
   PubMed Web of Science ®Google Scholar
• Rodriguez D, Almirante B, Cuenca-Estrella M, . Predictors of candidaemia caused by non-albicans Candida species: results of a population-based surveillance in Barcelona, Spain. Clin Microbiol Infect 2010; 16: 1676–1682.
   PubMed Web of Science ®Google Scholar
• Slavin MA, Sorrell TC, Marriott D, . Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death. J Antimicrob Chemother 2010; 65: 1042–1051.
   PubMed Web of Science ®Google Scholar